Researchers have examined the adverse outcomes of zafirlukast in adults and kids aged twelve or older. Occasional stories of eosinophilia accompanied by vasculitis in patients on zafirlukast have emerged. Zafirlukast is thoroughly hepatically metabolized by an enzyme identified as CYP2C9. Zafirlu